CurifyLabs has been granted Deep Tech Accelerator funding by Business Finland: RESEARCH RESULTS EXPECTED TO LEAD TO GLOBAL BREAKTHROUGHS
The total funding consists of two phases, the first of which is an EUR 400.000 grant and the second an EUR 1 million loan. Business Finland has made funding decisions for the first phase. The aim of the pilot funding call was to identify 10 promising startups from different sectors and to gain experience on the impact of funding on the development of research-driven companies. Business Finland ultimately granted funding to a total of 17 deep tech startups.
"Deep tech startups have a huge potential to disrupt entire industries."
Startups commercializing research results often develop solutions to global problems and have a significant market opportunity based on the intellectual property rights created in the research. Business Finland has been developing services for such companies for several years.
"I spent 10 years in academia developing a novel technology for automating pharmacy-tailored medicines. Having worked both in academia and in business, it's evident that that execution matters. Moving research from lab to the patient takes time and we're happy to receive this funding, which helps us is scaling the business and making an impact“, says Dr Niklas Sandler Topelius, CTO at CurifyLabs.